mRNA technology and the COVID-19 vaccine: A conversation with Pfizer’s Kathy Fernando
At the Intersection of Science and Law
English - September 03, 2021 16:45 - 26 minutes - 24.2 MBLife Sciences Science Technology covid19 fda mrna pfizer dlapiper law lawfirms legal pandemic vaccine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Next Episode: Understanding AI and its use in drug discovery
For decades, scientists have studied the seemingly endless possibilities of custom-made messenger RNA, or mRNA. Kathy Fernando, Head Vice President, Worldwide of Clinical Operations at Pfizer, spent her early bench science career working with mRNA technology and had a front row seat to the creation of the COVID-19 vaccine. DLA Piper’s Dr. Lisa Haile talks with Dr. Fernando about the study of mRNA and how COVID-19 catalyzed its advancement.
See omnystudio.com/listener for privacy information.